Adenocarcinoma of the Colon is the most common form of gastrointestinal cancer. Adenocarcinoma of the Colon begins with polyps that develop along the inner layer of the colon. It can then spread to the walls of the colon as well as many other organs. Adenocarcinoma of the Colon is usually found in people who have the cancer in their family history, along with middle aged people who are not screened regularly enough. This cancer is actually very curable with a 70 to 80 percent survival rate. The polyps are removed (typically by colonoscopy) which would also remove the cancerous tissues unless it has already spread too far.
Adenocarcinoma Of Colon Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Adenocarcinoma Of Colon below!
For more information on how to use Laverne, please read the How to Guide.
We have 4935 products for the study of Adenocarcinoma Of Colon that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Adenocarcinoma Of Colon is also known as Adenocarcinoma Of The Colon, Colon Adenocarcinoma, Colon Cancer, Adenocarcinoma, Colon, Adenocarcinoma Of The, Colonic Adenocarcinoma.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.